The global biotech ingredients market size is calculated at USD 2.59 billion in 2025 and is forecasted to reach around USD 5.10 billion by 2034, accelerating at a CAGR of 7.83% from 2025 to 2034. The Europe market size surpassed USD 910 million in 2024 and is expanding at a CAGR of 7.97% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Biotech Ingredients Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Biotech Ingredients Market Revenue and Volume, by Type
8.1.1 Active Pharmaceutical Ingredients (APIs)
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Biosimilars
8.1.2.1. Market Revenue and Volume Forecast
9.1. Biotech Ingredients Market Revenue and Volume, by Product
9.1.1. Monoclonal Antibodies
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Vaccines
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Hormones and Growth Factors
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Cytokines
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Fusion Proteins
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Therapeutic Enzymes
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Blood Factors
9.1.7.1. Market Revenue and Volume Forecast
10.1. Biotech Ingredients Market Revenue and Volume, by Expression System
10.1.1. Mammalian Expression Systems
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Microbial Expression Systems
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Yeast Expression Systems
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Plant Expression Systems
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Insect Expression Systems
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type
11.1.2. Market Revenue and Volume Forecast, by Product
11.1.3. Market Revenue and Volume Forecast, by Expression System
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type
11.1.4.2. Market Revenue and Volume Forecast, by Product
11.1.4.3. Market Revenue and Volume Forecast, by Expression System
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type
11.1.5.2. Market Revenue and Volume Forecast, by Product
11.1.5.3. Market Revenue and Volume Forecast, by Expression System
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type
11.2.2. Market Revenue and Volume Forecast, by Product
11.2.3. Market Revenue and Volume Forecast, by Expression System
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type
11.2.4.2. Market Revenue and Volume Forecast, by Product
11.2.4.3. Market Revenue and Volume Forecast, by Expression System
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type
11.2.5.2. Market Revenue and Volume Forecast, by Product
11.2.5.3. Market Revenue and Volume Forecast, by Expression System
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type
11.2.6.2. Market Revenue and Volume Forecast, by Product
11.2.6.3. Market Revenue and Volume Forecast, by Expression System
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type
11.2.7.2. Market Revenue and Volume Forecast, by Product
11.2.7.3. Market Revenue and Volume Forecast, by Expression System
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type
11.3.2. Market Revenue and Volume Forecast, by Product
11.3.3. Market Revenue and Volume Forecast, by Expression System
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type
11.3.4.2. Market Revenue and Volume Forecast, by Product
11.3.4.3. Market Revenue and Volume Forecast, by Expression System
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type
11.3.5.2. Market Revenue and Volume Forecast, by Product
11.3.5.3. Market Revenue and Volume Forecast, by Expression System
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type
11.3.6.2. Market Revenue and Volume Forecast, by Product
11.3.6.3. Market Revenue and Volume Forecast, by Expression System
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type
11.3.7.2. Market Revenue and Volume Forecast, by Product
11.3.7.3. Market Revenue and Volume Forecast, by Expression System
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type
11.4.2. Market Revenue and Volume Forecast, by Product
11.4.3. Market Revenue and Volume Forecast, by Expression System
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type
11.4.4.2. Market Revenue and Volume Forecast, by Product
11.4.4.3. Market Revenue and Volume Forecast, by Expression System
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type
11.4.5.2. Market Revenue and Volume Forecast, by Product
11.4.5.3. Market Revenue and Volume Forecast, by Expression System
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type
11.4.6.2. Market Revenue and Volume Forecast, by Product
11.4.6.3. Market Revenue and Volume Forecast, by Expression System
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type
11.4.7.2. Market Revenue and Volume Forecast, by Product
11.4.7.3. Market Revenue and Volume Forecast, by Expression System
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type
11.5.2. Market Revenue and Volume Forecast, by Product
11.5.3. Market Revenue and Volume Forecast, by Expression System
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type
11.5.4.2. Market Revenue and Volume Forecast, by Product
11.5.4.3. Market Revenue and Volume Forecast, by Expression System
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type
11.5.5.2. Market Revenue and Volume Forecast, by Product
11.5.5.3. Market Revenue and Volume Forecast, by Expression System
12.1. Fermenta Biotech Limited
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Titan Biotech
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Conagen, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Advanced Biotech
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bell Flavors & Fragrances, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Merck KGaA
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. International Flavors & Fragrances, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Amyris
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. DSM-Firmenich
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Symrise
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample